Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Gad Berdugo
General Partner,
Explorium Capital LLC

Fred Goodwin, M.D.
Professor of Psychiatry,
The George Washington University Medical Center.

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Michael Tew
Principal
SandHill RP

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

‘Patent Death Squads’ vs. Innovation

‘Patent Death Squads’ vs. Innovation

If hedge funds and copycats continue to take advantage of the PTAB’s bias against patent holders, it will choke off fundi...  Read more

James P. Pinkerton, Cures Strategy founder, Fox News Analyst, and Reagan White House alumni, Joins CMPI
  • CMPI
  • 01/05/2016

James P. Pinkerton, Cures Strategy founder, Fox News Analyst, and Reagan White House alumni, Joins CMPI

The Center for Medicine in the Public Interest announced the appointment of James P. Pinkerton as a senior fellow. ...  Read more

Obamacare's slippery slope to single-payer system

Obamacare's slippery slope to single-payer system

When it comes to health insurance available through Obamacare, the only thing that seems to be "universal" about it is di...  Read more

DRUGWONKS BLOG